|
|
|
| Clinical effect of Qingjin Huatan Decoction in the treatment of stroke associated pneumonia typed with syndrome of phlegm-heat obstructing lung |
| GUAN Jin-zhen ZHANG Yong CHEN Yao |
| The Third Department of Internal Medicine, Yangjiang Traditional Chinese Medicine Hospital of Guangdong Province,Yangjiang 529500, China |
|
|
|
|
Abstract Objective To explore the clinical effect of Qingjin Huatan Decoction in the treatment of stroke associated pneumonia. Methods A total of 80 patients with stroke associated pneumonia typed with syndrome of phlegm-heat obstructing lung treated in our hospital from February 2016 to July 2018 were selected as the research subjects, they were divided into control group and observation group according to the random number table method, with 40 cases in each group. The control group was treated with conventional antibiotics, the observation group was treated with Qingjin Huatan Decoction based on the control group. The traditional Chinese medicine symptom score and inflammatory indexes before and after treatment were compare between the two groups. The treatment effect were compared between the two groups. Results Before treatment, there was no significant difference in the score of traditional Chinese medicine symptoms between the two groups (P＞0.05). After treatment, the score of traditional Chinese medicine symptoms in the observation group was lower than that in the control group, the difference was statistically significant (P＜0.05). The total effective rate of treatment in the observation group was 95.00%, which was higher than 77.50% in the control group,the difference was statistically significant (P＜0.05). Before treatment, there were no significant differences in white blood cell count (WBC), neutrophil percentage, lymphocyte percentage, and C-reactive protein (CRP) levels between the two groups (P＞0.05). After treatment, the WBC, neutrophil percentage, and CRP levels in the observation group were lower than those in the control group, and the lymphocyte percentages was higher than that in the control group,the differences were statistically significant (P＜0.05). Conclusion Qingjin Huatan Decoction for the treatment of stroke associated pneumonia typed with syndrome of phlegm-heat obstructing lung can effectively improve patients′ traditional Chinese medicine symptom scores, alleviate inflammation, and is worthy of clinical promotion and application.
|
|
|
|
|
|
| [1] |
Heuschmann PU，Kolominsky-Rabas PL，Misselwitz B，et al.Predictors of in-hospital mortality and attributable risks of death after ischemic stroke: the German stroke registers study group[J].ACC Cur J Rev，2004，13（12）：1761-1768.
|
| [2] |
Loewenstern J，Kessler RA，Caridi J，et al.Cost of oropharyngeal dysphagia after stroke：protocol for a systematic review[J].BMJ open，2018，8（12）：e022775.
|
| [3] |
刘莹莹，刘持善，付秀丽，等.脑卒中相关性肺炎的危险因素[J].山东大学学报（医学版），2012，50（7）：60-64.
|
| [4] |
中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中华神经科杂志，2010，43（2）：146-153.
|
| [5] |
卒中并发肺炎研究组专家共识——卒中相关性肺炎的诊断[J].实用心脑肺血管病杂志，2016，24（1）：6.
|
| [6] |
李灿东，吴承玉.中医诊断学[M].北京：中国中医药出版社，2012：33-36.
|
| [7] |
郑筱萸.中药新药临床研究指导原则[M].2002 版.北京：中国医药科技出版社，2002：54-57.
|
| [8] |
蔡媛媛，黄丹，李丽荣.卒中相关肺炎及其干预措施[J].中国实验诊断学，2018，22（7）：1275-1277.
|
| [9] |
阳竞，胡海.脑卒中相关性肺炎患者多重耐药菌感染病原学特点与相关因素分析[J].临床和实验医学杂志，2018，17（13）：1400-1403.
|
| [10] |
杨道海，蒋同伯，余崇华.清补结合治疗卒中相关肺炎——余崇华治疗卒中相关肺炎经验[J].江西中医药大学学报，2017，29（3）：18-20.
|
| [11] |
王珩，刘琳，辛永飞，等.大柴胡汤治疗卒中相关肺炎临床观察[J].天津药学，2015，27（6）：35-37.
|
| [12] |
熊昕，杨健，翁栩，等.清金化痰汤对卒中相关性肺炎高危病人的预防作用研究[J].中西医结合心脑血管病杂志，2017，15（4）：479-480.
|
| [13] |
吴林娜，赵媚，许光兰.清金化痰汤通过调节自噬对COPD大鼠炎症反应的影响[J].中国实验方剂学杂志，2019，25（18）：30-35.
|
| [14] |
陈小梅，雷鸣，肖玮.清金化痰汤对老年肺炎患者的临床疗效及对炎性因子和巨噬细胞移动抑制因子的影响[J].成都中医药大学学报，2017，40（3）：80-82.
|
| [15] |
邹鹏，简小云，陈伟云，等.清金化痰汤治疗老年社区获得性肺炎的疗效观察[J].云南中医中药杂志，2019，40（5）：32-34.
|
|
|
|
